Antiplatelet drug ticagrelor delays gastric ulcer healing in rats.

about

Antiplatelet drug ticagrelor delays gastric ulcer healing in rats.

Item

http://www.wikidata.org/entity/Q42376424

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Antiplatelet drug ticagrelor delays gastric ulcer healing in rats.

@en

Antiplatelet drug ticagrelor delays gastric ulcer healing in rats.

@nl

type

Item

label

Antiplatelet drug ticagrelor delays gastric ulcer healing in rats.

@en

Antiplatelet drug ticagrelor delays gastric ulcer healing in rats.

@nl

prefLabel

Antiplatelet drug ticagrelor delays gastric ulcer healing in rats.

@en

Antiplatelet drug ticagrelor delays gastric ulcer healing in rats.

@nl

P1476

Antiplatelet drug ticagrelor delays gastric ulcer healing in rats.

@en

P2093

Guan-Rong Chen

http://www.w3.org/2001/XMLSchema#string

Hong-Ping Song

http://www.w3.org/2001/XMLSchema#string

Jing-Jing Li

http://www.w3.org/2001/XMLSchema#string

Jing-Lou Chen

http://www.w3.org/2001/XMLSchema#string

Jun Xu

http://www.w3.org/2001/XMLSchema#string

Xin-Ying Wu

http://www.w3.org/2001/XMLSchema#string

Ye Gu

http://www.w3.org/2001/XMLSchema#string

P2860

2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials

Platelets modulate gastric ulcer healing: role of endostatin and vascular endothelial growth factor release

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

Gastrointestinal adverse events after dual antiplatelet therapy: clopidogrel is safer than ticagrelor, but prasugrel data are lacking or inconclusive.

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevati

ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.

Inhibition of angiogenesis by NSAIDs: molecular mechanisms and clinical implications.

NF-kappa B: a new player in angiostatic therapy

The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation.

P304

3774-3779

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/ETM.2017.4955

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29042978

http://www.w3.org/2001/XMLSchema#string

P932

5639414

http://www.w3.org/2001/XMLSchema#string